ESR1 and breast carcinoma: Since CLOCK is a core transcription factor in mammalian circadian clock, it is reasonable to speculate that abnormal activation of E2-ERα signaling could induce the overexpression of CLOCK, and disrupt the circadian clock in breast cancer cells.